Metastatic Renal Cell Cancer, mRCC – Promising Treatment Option with Keytruda + Avastin
Published on February 25, 2020 Background This phase Ib/II study was designed to evaluate the safety and efficacy of a novel immunotherapy and VEGF-directed therapy combination as first line treatment…